246. Methylmalonic acidemia Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 23 / Drugs : 31 - (DrugBank : 8) / Drug target genes : 17 - Drug target pathways : 23
Methylmalonic acidemia and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
ID | Diseases (Sorted by drug repositionability) |
---|---|
246 | Methylmalonic acidemia |
236 | Pseudohypoparathyroidism |
63 | Idiopathic thrombocytopenic purpura |
226 | Interstitial cystitis with Hunners ulcer |
299 | Cystic fibrosis |
265 | Lipodystrophy |
78 | Hypopituitarism |
21 | Mitochondrial disease |
97 | Ulcerative colitis |
96 | Crohn disease |
2 | Amyotrophic lateral sclerosis |
46 | Malignant rheumatoid arthritis |
6 | Parkinson disease |
13 | Multiple sclerosis/Neuromyelitis optica |
162 | Pemphigoid |
56 | Behcet disease |
271 | Ankylosing spondylitis |
50 | Dermatomyositis |
107 | Juvenile idiopathic arthritis |
84 | Sarcoidosis |
8 | Huntington disease |
245 | Propionic acidemia |